To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene YARS2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
287 supporting clones for gene YARS2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA751860   YARS2.a 1 to 524 2 to 525   tiling clone, capped   524/524
(100 %)
1 diff
(99.9 %id)
DA748673   YARS2.a 9 to 571 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
CB988496 Human Placenta, placenta YARS2.a 21 to 719 28 to 727       700/782
(89 %)
4 diff
(99.5 %id)
CF594113 Human Placenta, placenta YARS2.a 21 to 659 29 to 672       644/807
(79 %)
9 diff
(98.9 %id)
NM_001040436.1   YARS2.a 21 to 2179 1 to 2159 exact RefSeq, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 2159/2159
(100 %)
0 diff
(100 %id)
BI835504 pooled pancreas and spleen YARS2.a 28 to 700 1 to 673       673/673
(100 %)
2 diff
(99.8 %id)
TI_57167239   YARS2.a 28 to 808 30 to 810       781/810
(96 %)
6 diff
(99.3 %id)
AL550526 placenta, Placenta Cot 25-normalized YARS2.a 32 to 799 1 to 768       768/768
(100 %)
0 diff
(100 %id)
BM788583 stomach YARS2.a 53 to 671 1 to 619       619/619
(100 %)
0 diff
(100 %id)
DA586536 lung YARS2.a 54 to 589 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA586694 lung YARS2.a 54 to 589 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DB134890 thymus YARS2.a 54 to 593 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA234356 brain YARS2.a 56 to 640 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DA634403 Kidney YARS2.a 56 to 618 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DB052873 testis YARS2.a 56 to 621 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AU098578   YARS2.a 57 to 356 1 to 300       300/300
(100 %)
10 diff
(96.7 %id)
BP220179 colon YARS2.a 57 to 606 1 to 550       550/550
(100 %)
10 diff
(98.2 %id)
CR621180 Placenta Cot 25-normalized YARS2.a 59 to 1541 1 to 1483 exact     1483/1483
(100 %)
0 diff
(100 %id)
AL552956 placenta, Placenta Cot 25-normalized YARS2.a 59 to 684 1 to 634   fully sequenced,   634/634
(100 %)
10 diff
(98.5 %id)
AK024057   YARS2.a 60 to 1698 1 to 1639 exact available from FLJ,   1639/1639
(100 %)
2 diff
(99.9 %id)
AK026619   YARS2.a 61 to 1698 1 to 1638 exact available from FLJ, AAA   1638/1638
(100 %)
0 diff
(100 %id)
BP273743   YARS2.a 61 to 629 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BM754661 stomach YARS2.a 61 to 430 1 to 370       370/370
(100 %)
4 diff
(99.0 %id)
BP356358   YARS2.a 61 to 642 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP377403 uterus YARS2.a 61 to 640 1 to 579       579/580
(99 %)
2 diff
(99.7 %id)
BP378223 uterus YARS2.a 61 to 640 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
AU143609   YARS2.a 61 to 790 2 to 738   capped   737/742
(99 %)
14 diff
(98.2 %id)
DA358661 subthalamic nucleus YARS2.a 62 to 637 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA426499 colon YARS2.a 62 to 640 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CA495262   YARS2.a 62 to 917 1 to 857       857/857
(100 %)
7 diff
(99.2 %id)
DA666638   YARS2.a 62 to 604 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM740837 stomach YARS2.a 62 to 699 1 to 638       638/638
(100 %)
2 diff
(99.7 %id)
DA927366 small intestine YARS2.a 62 to 633 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB125669 thymus YARS2.a 62 to 628 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB169423 kidney, tumor tissue YARS2.a 62 to 641 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
BE243834 leukopheresis YARS2.a 63 to 499 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
BP194162 brain YARS2.a 64 to 646 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA389708 thalamus YARS2.a 64 to 640 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
CD048249 embryonic stem cells, WA01, passage 38 YARS2.a 64 to 899 19 to 853       835/918
(90 %)
9 diff
(99.1 %id)
DB478315 hippocampus YARS2.a 64 to 556 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
BP250937 hippocampus YARS2.a 64 to 645 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA362884 subthalamic nucleus YARS2.a 65 to 633 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA444974 tongue, tumor tissue YARS2.a 65 to 636 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA476214   YARS2.a 65 to 623 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA519519 brain YARS2.a 65 to 612 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
DA533295 brain YARS2.a 65 to 619 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA591921 lung YARS2.a 65 to 616 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA606999   YARS2.a 65 to 618 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA609366   YARS2.a 65 to 609 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA742818   YARS2.a 65 to 612 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA952871 Spleen YARS2.a 65 to 611 2 to 552   capped   551/551
(100 %)
5 diff
(99.1 %id)
DB139283 thymus YARS2.a 65 to 614 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB244202 uterus, tumor tissue YARS2.a 65 to 613 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA203510 brain YARS2.a 69 to 655 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA790761 brain YARS2.a 70 to 624 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DB228972 trachea YARS2.a 70 to 663 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DB266148 uterus YARS2.a 70 to 654 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
BF966501 brain, hippocampus YARS2.a 73 to 852 1 to 787       787/902
(87 %)
34 diff
(96.3 %id)
BI551842 brain, hippocampus YARS2.a 73 to 782 1 to 711       711/712
(99 %)
6 diff
(99.2 %id)
BI199447 brain, neuroblastoma YARS2.a 74 to 985 1 to 915       915/980
(93 %)
50 diff
(94.9 %id)
BM926004 brain YARS2.a 74 to 867 18 to 810       793/1100
(72 %)
13 diff
(98.9 %id)
CN363006 embryonic stem cells, DMSO-treated H9 cellline YARS2.a 75 to 841 7 to 774       768/774
(99 %)
6 diff
(99.3 %id)
CN363001 embryonic stem cells, cell lines H1, H7, andH9 YARS2.a 76 to 536 1 to 461       461/461
(100 %)
3 diff
(99.4 %id)
BG619760 placenta YARS2.a 76 to 832 1 to 766       766/770
(99 %)
19 diff
(97.6 %id)
CX871031 embryonic stem YARS2.a 76 to 831 1 to 756       756/756
(100 %)
0 diff
(100 %id)
CR599422 HeLa cells Cot 25-normalized YARS2.a 77 to 1571 1 to 1495 exact     1495/1495
(100 %)
0 diff
(100 %id)
AL556461 placenta YARS2.a 77 to 1014 1 to 939       939/939
(100 %)
5 diff
(99.5 %id)
CX756150 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass YARS2.a 77 to 831 45 to 798     Submitted on the opposite strand 754/876
(86 %)
20 diff
(97.8 %id)
CR603090 neuroblastoma YARS2.a 78 to 1670 1 to 1593 exact     1593/1593
(100 %)
0 diff
(100 %id)
BX425961 neuroblastoma YARS2.a 78 to 1010 1 to 932       932/932
(100 %)
3 diff
(99.7 %id)
BX458128 neuroblastoma YARS2.a 78 to 1034 1 to 960       958/960
(99 %)
22 diff
(97.8 %id)
BM462852 melanotic melanoma, skin YARS2.a 78 to 867 1 to 795       795/1004
(79 %)
23 diff
(97.8 %id)
TI_44169781   YARS2.a 78 to 782 63 to 768       706/769
(91 %)
4 diff
(99.5 %id)
BQ643241 lymph, lymphoma, cell line YARS2.a 79 to 986 1 to 916       916/923
(99 %)
18 diff
(98.1 %id)
DB468266 hippocampus YARS2.a 80 to 506 1 to 427       427/427
(100 %)
1 diff
(99.8 %id)
BG739931 skin YARS2.a 80 to 867 1 to 813       813/1027
(79 %)
41 diff
(96.1 %id)
BJ991026 hepatoblastoma YARS2.a 81 to 660 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BG421768 Kidney, renal cell adenocarcinoma YARS2.a 81 to 855 1 to 773       773/843
(91 %)
25 diff
(97.1 %id)
BI839138 pooled pancreas and spleen YARS2.a 81 to 867 1 to 796       796/882
(90 %)
38 diff
(95.7 %id)
TI_57168392   YARS2.a 81 to 867 1 to 796       796/882
(90 %)
38 diff
(95.7 %id)
CD672300 eye, Iris YARS2.a 82 to 523 1 to 442       442/442
(100 %)
0 diff
(100 %id)
AA463810   YARS2.a 82 to 481 1 to 388       388/388
(100 %)
13 diff
(96.7 %id)
BI908713 leukocyte YARS2.a 82 to 700 1 to 620       620/620
(100 %)
3 diff
(99.6 %id)
TI_57234635   YARS2.a 82 to 827 34 to 780       747/780
(95 %)
6 diff
(99.3 %id)
TI_1948132378   YARS2.a 82 to 765 127 to 816   fully sequenced,   690/816
(84 %)
11 diff
(98.7 %id)
CX756817 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass YARS2.a 83 to 846 1 to 757     Submitted on the opposite strand 757/791
(95 %)
9 diff
(98.9 %id)
CR613924 B cells (Ramos cell line) YARS2.a 84 to 1574 1 to 1491 exact     1491/1491
(100 %)
0 diff
(100 %id)
AL560536 B cells (Ramos cell line), B cells from Burkitt lymphoma YARS2.a 84 to 789 1 to 707   fully sequenced,   707/707
(100 %)
6 diff
(99.2 %id)
BG748919 eye, normal pigmented retinal epithelium YARS2.a 84 to 827 1 to 744       744/744
(100 %)
1 diff
(99.9 %id)
DR007076 Spleen YARS2.a 84 to 814 38 to 768       731/768
(95 %)
6 diff
(99.3 %id)
BC015625 Eye, normal, pigmented retinal epithelium YARS2.a 85 to 1698 1 to 1614 exact available from MGC, AAA   1614/1614
(100 %)
0 diff
(100 %id)
CN363005 embryonic stem cells, DMSO-treated H9 cellline YARS2.a 86 to 841 9 to 764       756/764
(98 %)
6 diff
(99.3 %id)
CR602460 Neuroblastoma Cot 10-normalized YARS2.a 86 to 1682 1 to 1597 exact     1597/1597
(100 %)
0 diff
(100 %id)
CR616684 T cells (Jurkat cell line) YARS2.a 86 to 1596 1 to 1511 exact     1511/1511
(100 %)
0 diff
(100 %id)
AL583478 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized YARS2.a 86 to 867 1 to 782       782/1012
(77 %)
3 diff
(99.8 %id)
AL557124 T cells (Jurkat cell line), T cells from T cell leukemia YARS2.a 86 to 856 1 to 770       770/1105
(69 %)
1 diff
(100.0 %id)
BQ690039 ductal carcinoma, cell line, Pancreas YARS2.a 86 to 961 1 to 880       880/880
(100 %)
11 diff
(98.8 %id)
BQ949411 large cell carcinoma, lung YARS2.a 86 to 641 1 to 564       564/1014
(55 %)
37 diff
(96.4 %id)
CV028947 mixed YARS2.a 87 to 661 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
TI_1948132059   YARS2.a 87 to 947 123 to 981       859/1309
(65 %)
24 diff
(98.2 %id)
TI_1948132689   YARS2.a 87 to 973 123 to 1015   AAA   893/1344
(66 %)
31 diff
(97.7 %id)
TI_1948132690   YARS2.a 87 to 807 133 to 860       728/1075
(67 %)
11 diff
(99.0 %id)
TI_1948132999   YARS2.a 87 to 789 124 to 830       707/1344
(52 %)
32 diff
(97.7 %id)
TI_1948133000   YARS2.a 87 to 735 136 to 791       656/1163
(56 %)
17 diff
(98.6 %id)
CR600056 B cells (Ramos cell line) YARS2.a 88 to 1768 1 to 1681   tiling clone,   1681/1681
(100 %)
0 diff
(100 %id)
BX426353 B cells (Ramos cell line) YARS2.a 88 to 920 1 to 833   fully sequenced,   833/833
(100 %)
0 diff
(100 %id)
BG576920 breast, mammary adenocarcinoma, cell line YARS2.a 90 to 880 1 to 790       790/790
(100 %)
8 diff
(99.0 %id)
BX424533 placenta YARS2.a 91 to 922 1 to 830       830/830
(100 %)
11 diff
(98.7 %id)
BX446792 neuroblastoma YARS2.a 91 to 1000 1 to 909       909/912
(99 %)
21 diff
(97.7 %id)
BE784158 eye, retinoblastoma YARS2.a 91 to 845 1 to 754       754/1046
(72 %)
17 diff
(98.4 %id)
BQ948022 epidermoid carcinoma, cell line, lung YARS2.a 91 to 847 1 to 765       765/857
(89 %)
11 diff
(98.8 %id)
BQ962898 leiomyosarcoma, uterus YARS2.a 91 to 984 1 to 904       904/904
(100 %)
19 diff
(97.9 %id)
BE536992 cervix YARS2.a 92 to 864 1 to 770       770/822
(93 %)
48 diff
(94.2 %id)
TI_57179171   YARS2.a 92 to 972 26 to 901       876/903
(97 %)
14 diff
(98.5 %id)
AA305940   YARS2.a 94 to 512 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
BI769402 pooled lung and spleen YARS2.a 96 to 700 1 to 605       605/605
(100 %)
3 diff
(99.6 %id)
BQ056148 lymph, lymphoma, cell line YARS2.a 96 to 1032 1 to 943       943/1002
(94 %)
28 diff
(97.3 %id)
BE783020 eye, retinoblastoma YARS2.a 98 to 803 1 to 695       695/881
(78 %)
11 diff
(98.8 %id)
CN363000 embryonic stem cells, DMSO-treated H9 cellline YARS2.a 102 to 659 1 to 558       558/559
(99 %)
2 diff
(99.7 %id)
CN363004 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells YARS2.a 103 to 313 1 to 211       211/211
(100 %)
1 diff
(99.6 %id)
BE279116 choriocarcinoma, placenta YARS2.a 105 to 791 1 to 683       683/684
(99 %)
6 diff
(99.2 %id)
BE388329 endometrium, adenocarcinoma cell line, uterus YARS2.a 105 to 749 1 to 642       642/642
(100 %)
15 diff
(97.7 %id)
BE384474 melanotic melanoma, skin YARS2.a 105 to 786 1 to 678       678/700
(96 %)
11 diff
(98.5 %id)
BG488628 large cell carcinoma, lung YARS2.a 106 to 760 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
CX761140 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass YARS2.a 106 to 782 1 to 669     Submitted on the opposite strand 669/801
(83 %)
16 diff
(98.1 %id)
BE782452 eye, retinoblastoma YARS2.a 107 to 736 1 to 630       630/632
(99 %)
1 diff
(99.9 %id)
BQ935733 large cell carcinoma, lung YARS2.a 108 to 1032 1 to 937       937/941
(99 %)
50 diff
(94.7 %id)
TI_1948132060   YARS2.a 109 to 762 154 to 819   AAA   666/1163
(57 %)
30 diff
(97.5 %id)
BE747257 adenocarcinoma cell line, ovary YARS2.a 116 to 867 1 to 749       749/978
(76 %)
12 diff
(98.8 %id)
CX752774 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass YARS2.a 122 to 834 34 to 745     Submitted on the opposite strand 712/745
(95 %)
6 diff
(99.2 %id)
BE873633 adenocarcinoma, colon YARS2.a 192 to 465 1 to 274       274/274
(100 %)
0 diff
(100 %id)
CX760374 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass YARS2.a 202 to 886 47 to 732     Submitted on the opposite strand 686/740
(92 %)
6 diff
(99.2 %id)
CR983905 T-Lymphocytes YARS2.a 202 to 344 14 to 156       143/156
(91 %)
5 diff
(96.8 %id)
CN362998 embryonic stem cells, DMSO-treated H9 cellline YARS2.a 212 to 618 1 to 407       407/407
(100 %)
3 diff
(99.3 %id)
CN362997 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells YARS2.a 215 to 631 1 to 417       417/417
(100 %)
1 diff
(99.8 %id)
AA305890   YARS2.a 217 to 779 1 to 559       559/560
(99 %)
9 diff
(98.4 %id)
CX869746 embryonic stem YARS2.a 231 to 901 1 to 671       671/671
(100 %)
1 diff
(99.9 %id)
BI093579 cervix YARS2.a 259 to 903 1 to 645       645/645
(100 %)
1 diff
(99.9 %id)
DR763577 embryonic stem YARS2.a 350 to 1165 13 to 828       816/828
(98 %)
6 diff
(99.3 %id)
CX786512 human embryonic stem cells YARS2.a 378 to 1182 1 to 804       804/804
(100 %)
2 diff
(99.8 %id)
TI_44343193   YARS2.a 428 to 883 123 to 583       461/585
(78 %)
12 diff
(98.0 %id)
BI666741 brain, hypothalamus YARS2.a 432 to 883 1 to 457       457/459
(99 %)
10 diff
(97.9 %id)
TI_154186152   YARS2.a 434 to 1187 84 to 834       751/1068
(70 %)
16 diff
(98.6 %id)
TI_154186153   YARS2.a 434 to 1360 82 to 998       919/1117
(82 %)
37 diff
(96.7 %id)
TI_154188273   YARS2.a 434 to 1141 82 to 789       708/1086
(65 %)
24 diff
(97.8 %id)
AU123464   YARS2.a 451 to 1246 2 to 795   capped   794/794
(100 %)
3 diff
(99.7 %id)
DB506006 hypothalamus YARS2.a 474 to 780 1 to 307       307/307
(100 %)
4 diff
(98.7 %id)
BI090442 cervix YARS2.a 499 to 1195 1 to 695       695/749
(92 %)
11 diff
(98.6 %id)
AA357075   YARS2.a 544 to 890 1 to 350       350/352
(99 %)
5 diff
(98.6 %id)
AL578710 placenta YARS2.a 551 to 1534 978 to 1       978/978
(100 %)
10 diff
(99.0 %id)
AA341406 Kidney YARS2.a 584 to 811 1 to 228       228/228
(100 %)
1 diff
(99.6 %id)
AA663785 schizophrenic brain S-11 frontal lobe YARS2.a 617 to 1000 100 to 483     Submitted on the opposite strand 384/483
(79 %)
7 diff
(98.6 %id)
TI_1948132691   YARS2.a 641 to 1524 1015 to 117       899/1211
(74 %)
26 diff
(97.9 %id)
AL576181 placenta, Placenta Cot 25-normalized YARS2.a 654 to 1541 880 to 1   fully sequenced,   880/880
(100 %)
3 diff
(99.7 %id)
BX425960 neuroblastoma YARS2.a 685 to 1670 985 to 1       985/991
(99 %)
5 diff
(99.5 %id)
TI_1948132061   YARS2.a 693 to 1524 958 to 120       839/1219
(68 %)
12 diff
(99.1 %id)
BM146615 leukopheresis YARS2.a 710 to 1153 1 to 444       444/444
(100 %)
2 diff
(99.6 %id)
BG876984 head_neck YARS2.a 727 to 1166 1 to 439       439/439
(100 %)
16 diff
(96.4 %id)
TI_1948132379   YARS2.a 735 to 1524 918 to 117   fully sequenced,   802/918
(87 %)
16 diff
(98.3 %id)
CN362999 embryonic stem cells, cell lines H1, H7, andH9 YARS2.a 752 to 1276 24 to 548       525/548
(95 %)
6 diff
(99.0 %id)
AL581970 B cells (Ramos cell line), B cells from Burkitt lymphoma YARS2.a 759 to 1547 818 to 34   fully sequenced,   785/818
(95 %)
3 diff
(99.7 %id)
TI_1948133001   YARS2.a 763 to 1524 892 to 118       775/1277
(60 %)
19 diff
(98.6 %id)
BE799465 lung, small cell carcinoma YARS2.a 780 to 1535 41 to 787       747/998
(74 %)
15 diff
(98.5 %id)
BE881857 leiomyosarcoma, uterus YARS2.a 795 to 1549 1 to 746       746/939
(79 %)
25 diff
(97.4 %id)
CN363003 embryonic stem cells, DMSO-treated H9 cellline YARS2.a 838 to 1508 6 to 676       671/676
(99 %)
6 diff
(99.2 %id)
AL520131 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized YARS2.a 858 to 1682 825 to 1       825/1124
(73 %)
26 diff
(97.7 %id)
AL579229 T cells (Jurkat cell line), T cells from T cell leukemia YARS2.a 858 to 1596 739 to 1       739/970
(76 %)
23 diff
(97.7 %id)
AW606631 head_neck YARS2.a 866 to 1009 147 to 5       143/151
(94 %)
0 diff
(100 %id)
AW606746 head_neck YARS2.a 866 to 1009 147 to 5       143/151
(94 %)
0 diff
(100 %id)
AL574470 placenta, Placenta Cot 25-normalized YARS2.a 866 to 1671 822 to 17       806/822
(98 %)
1 diff
(99.9 %id)
BX426352 B cells (Ramos cell line) YARS2.a 890 to 1768 871 to 1   fully sequenced,   871/871
(100 %)
17 diff
(98.1 %id)
BX390025   YARS2.a 892 to 1571 1 to 680       680/680
(100 %)
3 diff
(99.6 %id)
BX390026   YARS2.a 892 to 1569 1 to 678       678/678
(100 %)
2 diff
(99.8 %id)
AW511493 pooled germ cell tumors YARS2.a 903 to 1572 670 to 1       670/670
(100 %)
6 diff
(99.2 %id)
AI653357 pooled germ cell tumors YARS2.a 927 to 1702 774 to 1       774/774
(100 %)
6 diff
(99.3 %id)
AW237063 pooled germ cell tumors YARS2.a 933 to 1572 640 to 1       640/640
(100 %)
1 diff
(99.9 %id)
AA747428 germinal center B cell YARS2.a 945 to 1698 771 to 19   AAA   753/753
(100 %)
8 diff
(99.0 %id)
AA622511 colon, colon tumor RER+ YARS2.a 957 to 1697 741 to 1       741/741
(100 %)
16 diff
(97.9 %id)
AI989806 pooled germ cell tumors YARS2.a 957 to 1572 617 to 1       617/617
(100 %)
1 diff
(99.9 %id)
BU624190 cell lines, Enchondroma YARS2.a 1006 to 1698 710 to 19   AAA   692/692
(100 %)
1 diff
(99.9 %id)
AI761558 colon, colon tumor, RER+ YARS2.a 1017 to 1698 685 to 1       685/685
(100 %)
5 diff
(99.3 %id)
BE872682 adenocarcinoma, colon YARS2.a 1022 to 1544 1 to 540       540/781
(69 %)
32 diff
(96.0 %id)
AI417969 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus YARS2.a 1068 to 1695 627 to 1       627/627
(100 %)
1 diff
(99.9 %id)
AA625298 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus YARS2.a 1074 to 1701 1 to 628       628/628
(100 %)
1 diff
(99.9 %id)
BI091472 cervix YARS2.a 1082 to 1700 1 to 619       619/634
(97 %)
1 diff
(99.9 %id)
TI_157602597   YARS2.a 1091 to 1698 712 to 105   AAA   608/785
(77 %)
6 diff
(99.3 %id)
AA576313 breast, breast tumor YARS2.a 1104 to 1533 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AA773026   YARS2.a 1119 to 1699 582 to 2       581/582
(99 %)
1 diff
(99.9 %id)
BX115035   YARS2.a 1120 to 1698 1 to 579   AAA   579/579
(100 %)
0 diff
(100 %id)
AA393651   YARS2.a 1120 to 1408 1 to 289   fully sequenced,   289/289
(100 %)
0 diff
(100 %id)
BF032640 adenocarcinoma, ovary YARS2.a 1126 to 1682 1 to 560       560/837
(66 %)
6 diff
(99.3 %id)
BU616843 Cell Line, Chondrosarcoma YARS2.a 1138 to 1698 576 to 16   AAA   561/561
(100 %)
0 diff
(100 %id)
AW081433 colon, moderately differentiated adenocarcinoma YARS2.a 1141 to 1700 560 to 1       560/564
(99 %)
8 diff
(98.6 %id)
BF590565 colon, colon tumor, RER+ YARS2.a 1143 to 1695 553 to 1       553/553
(100 %)
0 diff
(100 %id)
BF063660 colon, colon tumor, RER+ YARS2.a 1152 to 1695 544 to 1       544/544
(100 %)
0 diff
(100 %id)
BQ012725 placenta YARS2.a 1163 to 1698 551 to 16   AAA   536/536
(100 %)
1 diff
(99.9 %id)
BF939126 carcinoid, lung YARS2.a 1164 to 1700 537 to 2       536/537
(99 %)
0 diff
(100 %id)
BF062975 colon, colon tumor, RER+ YARS2.a 1184 to 1697 514 to 1       514/552
(93 %)
10 diff
(98.2 %id)
CF995372 Pooled Chondrosarcoma Tumor cells YARS2.a 1214 to 1696 88 to 571       484/1098
(44 %)
29 diff
(97.4 %id)
CF529508 placenta YARS2.a 1217 to 1698 497 to 16   AAA   482/482
(100 %)
0 diff
(100 %id)
AU160677   YARS2.a 1218 to 1698 480 to 1       480/549
(87 %)
9 diff
(98.4 %id)
DB577312 hypothalamus YARS2.a 1226 to 1698 1 to 474     Submitted on the opposite strand 474/474
(100 %)
6 diff
(98.8 %id)
AA460246   YARS2.a 1226 to 1700 478 to 4       475/478
(99 %)
0 diff
(100 %id)
CX869663 embryonic stem YARS2.a 1247 to 1698 484 to 33   AAA   452/452
(100 %)
4 diff
(99.2 %id)
AA903035 leiomyosarcoma, soft tissue YARS2.a 1249 to 1635 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI992092 pooled germ cell tumors YARS2.a 1254 to 1700 447 to 1       447/447
(100 %)
0 diff
(100 %id)
BF593194 Kidney YARS2.a 1255 to 1700 451 to 5       447/451
(99 %)
2 diff
(99.6 %id)
AW206260   YARS2.a 1275 to 1698 441 to 18   AAA   424/425
(99 %)
6 diff
(98.6 %id)
AA447204   YARS2.a 1286 to 1700 416 to 2       415/416
(99 %)
0 diff
(100 %id)
N90490 liver and spleen YARS2.a 1291 to 1478 1 to 189       189/189
(100 %)
1 diff
(99.5 %id)
AI280277 placenta YARS2.a 1294 to 1700 409 to 3       407/409
(99 %)
0 diff
(100 %id)
BE468152 carcinoid, lung YARS2.a 1298 to 1702 410 to 6       405/410
(98 %)
0 diff
(100 %id)
DB509018 testis YARS2.a 1299 to 1702 1 to 404     Submitted on the opposite strand 404/404
(100 %)
3 diff
(99.3 %id)
AA719986 heart YARS2.a 1312 to 1704 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
BQ015683 placenta YARS2.a 1316 to 1698 400 to 18   AAA   383/383
(100 %)
1 diff
(99.8 %id)
AA514792 colon YARS2.a 1318 to 1698 381 to 1       381/381
(100 %)
0 diff
(100 %id)
AI420309 Prostate YARS2.a 1327 to 1699 377 to 1       377/377
(100 %)
15 diff
(96.1 %id)
EC531198 Prostate YARS2.a 1365 to 1469 109 to 5       105/109
(96 %)
0 diff
(100 %id)
AI672368 Kidney YARS2.a 1375 to 1700 333 to 8       326/333
(97 %)
0 diff
(100 %id)
AA400835   YARS2.a 1378 to 1698 321 to 1   fully sequenced,   321/321
(100 %)
2 diff
(99.4 %id)
AI656766 pooled germ cell tumors YARS2.a 1406 to 1700 295 to 1       295/295
(100 %)
0 diff
(100 %id)
AI200199 lung YARS2.a 1412 to 1698 287 to 1       287/287
(100 %)
0 diff
(100 %id)
N74113 lung YARS2.a 1423 to 1698 279 to 1       279/301
(92 %)
5 diff
(98.4 %id)
AA742236 germinal center B cell YARS2.a 1426 to 1698 291 to 19   AAA   273/273
(100 %)
0 diff
(100 %id)
AA639420 colon, colon tumor RER+ YARS2.a 1437 to 1677 242 to 1       242/242
(100 %)
10 diff
(95.9 %id)
AA947985 pooled YARS2.a 1438 to 1700 269 to 7       263/269
(97 %)
0 diff
(100 %id)
AI208423   YARS2.a 1459 to 1700 246 to 5       242/246
(98 %)
0 diff
(100 %id)
AI658738 Prostate YARS2.a 1485 to 1699 215 to 1       215/215
(100 %)
0 diff
(100 %id)
AW582780   YARS2.a 1496 to 1665 173 to 1       173/173
(100 %)
3 diff
(98.3 %id)
BE670905 carcinoid, lung YARS2.a 1501 to 1700 201 to 2       200/201
(99 %)
0 diff
(100 %id)
EB386795 eye, optic nerve YARS2.a 1517 to 2179 1 to 663   AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 663/663
(100 %)
6 diff
(99.1 %id)
BJ991027 hepatoblastoma YARS2.a 1636 to 2175 540 to 1       540/540
(100 %)
2 diff
(99.7 %id)
DW422010 Liver YARS2.a 1673 to 1958 10 to 295       286/295
(96 %)
6 diff
(98.0 %id)
AI861961 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus YARS2.a 1729 to 2180 452 to 1   tiling clone,   452/452
(100 %)
3 diff
(99.4 %id)
DW420740 Liver YARS2.a 1769 to 2051 17 to 299       283/299
(94 %)
6 diff
(98.0 %id)
BE243385 leukopheresis YARS2.a 1791 to 2179 389 to 1       389/389
(100 %)
4 diff
(99.0 %id)
N69226 liver and spleen YARS2.a 1890 to 2180 291 to 1   tiling clone,   291/291
(100 %)
0 diff
(100 %id)
BU955316 mixed (pool of 40 RNAs) YARS2.b 1 to 738 1 to 738 exact tiling clone,   738/738
(100 %)
10 diff
(98.7 %id)
DA381715 thalamus YARS2.c-u 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
T70427 liver and spleen YARS2.c-u 455 to 833 1 to 393   tiling clone,   393/415
(94 %)
14 diff
(96.7 %id)
T86008 liver and spleen YARS2.c-u 455 to 875 1 to 443   tiling clone,   443/476
(93 %)
30 diff
(93.7 %id)
N55984   YARS2.c-u 886 to 1048 1 to 162   tiling clone,   162/162
(100 %)
4 diff
(97.6 %id)
BF329038 breast_normal YARS2.c-u 1063 to 1481 420 to 3   tiling clone,   418/429
(97 %)
0 diff
(100 %id)
BF329050 breast_normal YARS2.c-u 1063 to 1476 416 to 2       415/425
(97 %)
0 diff
(100 %id)
BF329068 breast_normal YARS2.c-u 1066 to 1534 1 to 473       473/474
(99 %)
13 diff
(97.3 %id)
BF329080 breast_normal YARS2.c-u 1068 to 1534 1 to 470       470/471
(99 %)
11 diff
(97.7 %id)
BF329071 breast_normal YARS2.c-u 1071 to 1534 3 to 467       465/468
(99 %)
19 diff
(96.0 %id)
BE816893 breast_normal YARS2.c-u 1079 to 1534 10 to 468       459/469
(97 %)
6 diff
(98.8 %id)
BF329045 breast_normal YARS2.c-u 1116 to 1534 1 to 418       418/441
(94 %)
14 diff
(96.9 %id)
DA945113 Spleen YARS2.c-u 1220 to 1776 2 to 558   tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
AW516779 cervix, tumor YARS2.c-u 1429 to 1936 511 to 4   tiling clone,   508/511
(99 %)
0 diff
(100 %id)
W26056 eye, retina YARS2.c-u 1461 to 1963 4 to 507       504/526
(95 %)
0 diff
(100 %id)
AI808848 pooled YARS2.c-u 1511 to 1951 448 to 9   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 440/448
(98 %)
0 diff
(100 %id)
BE385485 melanotic melanoma, skin YARS2.c-u 1646 to 2098 1 to 455       455/455
(100 %)
20 diff
(95.7 %id)
T70342 liver and spleen YARS2.c-u 1827 to 2257 444 to 4   tiling clone,   441/449
(98 %)
0 diff
(100 %id)
CR990479 T-Lymphocytes YARS2.c-u 1850 to 2139 1 to 290   tiling clone,   290/292
(99 %)
1 diff
(99.7 %id)
DB311453 thalamus YARS2.c-u 2577 to 3097 522 to 1   tiling clone,   522/522
(100 %)
1 diff
(99.9 %id)
AI890619 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus YARS2.c-u 2645 to 3098 454 to 1   tiling clone,   454/454
(100 %)
5 diff
(98.9 %id)
AW515432 Kidney, renal cell tumor YARS2.c-u 2746 to 3097 351 to 1       351/351
(100 %)
4 diff
(98.9 %id)
BI090924 cervix YARS2.d-u 1 to 606 12 to 630 G22R F23I G24W I25N K26Q ... tiling clone,   619/931
(66 %)
20 diff
(97.9 %id)
AA236613 germinal center B cell YARS2.d-u 588 to 1008 1 to 421   tiling clone, fully sequenced,   421/421
(100 %)
5 diff
(98.9 %id)
AA838131 ovary YARS2.d-u 750 to 1011 1 to 262       262/269
(97 %)
5 diff
(98.2 %id)
DB518016 testis YARS2.d-u 755 to 1184 430 to 1       430/430
(100 %)
0 diff
(100 %id)
DB529599.
matches multiple genes
hippocampus YARS2.d-u 755 to 1191 439 to 1     also hits gene DNM1L 439/439
(100 %)
10 diff
(97.8 %id)
DB545361.
matches multiple genes
hippocampus YARS2.d-u 755 to 1051 297 to 1     also hits gene DNM1L 297/297
(100 %)
0 diff
(100 %id)
AW059948   YARS2.d-u 757 to 817 1 to 61       61/61
(100 %)
2 diff
(96.8 %id)
DB519909.
matches multiple genes
testis YARS2.d-u 758 to 1187 430 to 1     also hits gene DNM1L 430/430
(100 %)
0 diff
(100 %id)
DB522355 testis YARS2.d-u 758 to 1218 461 to 1       461/461
(100 %)
0 diff
(100 %id)
DB533824 hippocampus YARS2.d-u 758 to 1166 409 to 1       409/409
(100 %)
3 diff
(99.3 %id)
DB547476 hippocampus YARS2.d-u 758 to 1190 433 to 1       433/433
(100 %)
0 diff
(100 %id)
DB549474.
matches multiple genes
hippocampus YARS2.d-u 760 to 1199 440 to 1     also hits gene DNM1L 440/440
(100 %)
0 diff
(100 %id)
DB557219 hypothalamus YARS2.d-u 760 to 1195 442 to 1       442/442
(100 %)
13 diff
(97.1 %id)
DB570405 hypothalamus YARS2.d-u 760 to 1267 508 to 1       508/508
(100 %)
1 diff
(99.9 %id)
DB572483 hypothalamus YARS2.d-u 760 to 1244 485 to 1       485/485
(100 %)
0 diff
(100 %id)
BF753819 colon YARS2.d-u 761 to 1174 1 to 414       414/414
(100 %)
12 diff
(97.2 %id)
BF753954 colon YARS2.d-u 764 to 1238 23 to 497       475/497
(95 %)
6 diff
(98.8 %id)
AA831619 germinal center B cell YARS2.d-u 901 to 1355 456 to 2   tiling clone,   455/456
(99 %)
0 diff
(100 %id)
BE827788 lung_tumor YARS2.d-u 963 to 1320 1 to 359       359/363
(98 %)
8 diff
(97.8 %id)
AA237029 germinal center B cell YARS2.d-u 978 to 1347 370 to 1   fully sequenced,   370/370
(100 %)
0 diff
(100 %id)
AW368575 head_neck YARS2.d-u 1124 to 1257 1 to 132       132/136
(97 %)
8 diff
(94.2 %id)
H46440 brain YARS2.d-u 1359 to 1664 1 to 308   tiling clone,   308/463
(66 %)
8 diff
(98.3 %id)
H41175 brain YARS2.d-u 1370 to 1579 1 to 211       211/211
(100 %)
1 diff
(99.6 %id)
CN363002 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells YARS2.e 1 to 746 1 to 747 G111V tiling clone,   747/747
(100 %)
4 diff
(99.5 %id)
AV751512 Pituitary YARS2.e 684 to 1393 1 to 652   tiling clone, Suspected internal deletion 652/854
(76 %)
9 diff
(99.0 %id)
CB269117 adipose YARS2.f 1 to 529 1 to 529 exact tiling clone,   529/529
(100 %)
0 diff
(100 %id)
BF214198 bone marrow, from acute myelogenous leukemia YARS2.f 140 to 725 1 to 584   tiling clone,   584/849
(68 %)
14 diff
(98.4 %id)
BE328499 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney YARS2.f 236 to 680 449 to 1   tiling clone,   449/449
(100 %)
48 diff
(89.4 %id)
BE018780 cervix YARS2.f 695 to 945 1 to 258   tiling clone,   258/258
(100 %)
13 diff
(95.0 %id)
BQ011300 placenta YARS2.g-u 1 to 412 430 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (20/20 A in genome downstream of last aligned base) 412/412
(100 %)
3 diff
(99.3 %id)
AI678216 Prostate YARS2.g-u 17 to 414 397 to 1   tiling clone,   397/397
(100 %)
3 diff
(99.3 %id)
AF132939   Gene YARS2, variant not shown         This clone was ignored    
AK130935 uterus Gene YARS2, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
CR741800 pooled Gene YARS2, variant not shown         This clone was ignored    
BX497017 Liver Gene YARS2, variant not shown         This clone was ignored    
H46984 brain Gene YARS2, variant not shown         Submitted on the opposite strand    
R89306 liver and spleen Gene YARS2, variant not shown         Suspected internal deletion, this clone was ignored    
R89307 liver and spleen Gene YARS2, variant not shown         Suspected internal deletion, this clone was ignored    
H65570 liver and spleen Gene YARS2, variant not shown         Suspected internal deletion, this clone was ignored    
AA284398 germinal center B cell Gene YARS2, variant not shown         This clone was ignored    
AA287010 germinal center B cell Gene YARS2, variant not shown         This clone was ignored    
BE895196 melanotic melanoma, skin Gene YARS2, variant not shown         This clone was ignored    
BG258012 embryonal carcinoma, cell line, testis Gene YARS2, variant not shown         This clone was ignored    
BM663711 eye, Retina Foveal and Macular Gene YARS2, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BM690830 eye, Retina Foveal and Macular Gene YARS2, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
BM664910.
matches multiple genes
eye, optic nerve Gene YARS2, variant not shown       AAA This clone was ignored, also hits gene SNX14    
BM664910.
matches multiple genes
eye, optic nerve Gene SNX14, variant not shown       AAA This clone was ignored, also hits gene SNX14    
BM702223.
matches multiple genes
eye, optic nerve Gene YARS2, variant not shown         This clone was ignored, also hits gene SNX14    
BM702223.
matches multiple genes
eye, optic nerve Gene SNX14, variant not shown         This clone was ignored, also hits gene SNX14    
BP378343 uterus Gene YARS2, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d-u, .e, .f, .g-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI